Dr. Novotny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Vapa Health Care Systems, 3801 Miranda Ave
Palo Alto, CA 94304Phone+1 650-493-5000
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1986 - 1990
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1983 - 1986
- University of California San Diego School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1991 - 2026
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 70 citationsRandomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metas...David H Johnson, Louis Fehrenbacher, William F Novotny, Roy S Herbst, John J Nemunaitis
Journal of Clinical Oncology. 2023-05-01 - 158 citationsEfficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of-Overexpressing Metastatic Breast Cancer.Charles L Vogel, Melody A Cobleigh, Debu Tripathy, John C Gutheil, Lyndsay N Harris
Journal of Clinical Oncology. 2023-03-20 - 2 citationsZanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis.Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li
Leukemia & Lymphoma. 2023-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: